New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
05:46 EDTVNDAVanda Pharmaceuticals upgraded to Buy from Hold at Jefferies
Jefferies upgraded Vanda Pharmaceuticals citing positive sleep efficacy data for the company's tasimelteon drug. The firm raised its price target for shares to $6.00 from $3.50.
News For VNDA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
19:32 EDTVNDAOn The Fly: After Hours Movers
Subscribe for More Information
16:21 EDTVNDAVanda raises FY15 Hetlioz, Fanapt sales to $100M-$115M from $95M-$110M
FY15 revenue consensus is $104.18M. Sees Hetlioz sales $40M-$45M. Raises Fanapt sales to $60M-$70M from $55M-$65M.
16:18 EDTVNDAVanda reports Q2 adjusted EPS (1c), may not compare to two estimates (29c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use